SPDR S&P Biotech (ETF) news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

XBI 246.94 -2.28 (-0.91%)
price chart
XBI - Your Best ETF to Buy Now
StateStreetSPDR185 XBI Your Best ETF to Buy Now Enter the SPDR S&P Biotech (ETF) (NYSEARCA:XBI). This sector fund is focused on the reliable growth of healthcare - a segment of the market every investor should be overweight in.
The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR ...
Stocks recently featured in the blog include the iShares Nasdaq Biotechnology ETF (Nasdaq: IBB-Free Report), SPDR S&P Biotech ETF (AMEX: XBI-Free Report), First Trust NYSE Arca Biotechnology Index Fund (AMEX: FBT-Free Report), Market Vectors ...
The Complete Guide to Biotech ETFs - ETF News And Commentary  NASDAQ
Israeli Biotech Stocks Offer Low Returns For High Risk Investment  Seeking Alpha (registration)
Related articles »  
Triple-Leveraged Biotech ETFs Could be Coming Soon
The Direxion Daily S&P Biotech Bull 3X Shares would attempt to deliver three times the daily performance of the S&P Biotechnology Select Industry Index.
Direxion Plans Two Triple-Leveraged Biotech ETFs - ETF News And Commentary  Nasdaq
SPDR S&P Biotech ETF - Trading Analysis
There was interesting put volume activity today for SPDR S&P Biotech ETF, where 1.4 puts traded for each call contract yielding a 1.37 put/call ratio.
SPDR Series Trust - SPDR S&P Biotech ETF (XBI) - Trade Flow Report
SPDR Series Trust - SPDR S&P Biotech ETF options set a new 90-day record for the number of call contracts that exchanged hands between the buyers and the sellers.
Closing Bell Reports: SPDR Series Trust - SPDR S&P Homebuilders ETF (XHB ...  WallStreet Scope
BGC Partners' Jared Woodard Option Strategy For SPDR S&P Retail (ETF)  Benzinga
'Don't Give Up On Biotech Yet,' Says This CFA
As a result, focusing on the large biotech names might not be the best way to play the industry's advances in Lackey's view.
Biotech Stocks Set to Soar, So Buy This Top Biotech ETF  Investorplace.com
3 Types of Risks Facing Biotech Stocks  Motley Fool
Time To Sell The SPDR Biotech ETF
Even with forward earnings, the portfolio trades at 33.4x P/E. Even by biotech standards(21x forward earnings) the valuation is stretched.
A New Biotech ETF Could Challenge Established Rivals  ETF Trends
Back in the Lab: Triple-Leveraged Biotech ETFs are Here
The S&P Biotechnology Select Industry Index is the underlying benchmark for the well-known SPDR S&P Biotech ETF (NYSEArca: XBI), the third-largest biotech ETF by assets.
Move Over Hedge Funds, ETF's Are Taking Over  CNA Finance (press release)
Options Highlights for SPDR S&P Biotech ETF
SPDR S&P Biotech ETF options contracts experienced a new ninety day record for call contracts where a total of 2.98K call contracts were traded in the busy trading session.
Closing Bell Reports: CorMedix, Inc. (CRMD), Ericsson (ERIC), SPDR S&P ...  WallStreet Scope
Two Big Biotech ETFs
That includes the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotech Index, and the SPDR S&P Biotech ETF (NYSEArca: XBI), the third-largest biotech ETF by assets. [Biotech ETFs for the Long Term]. IBB, the largest ...